Columbia Sportswear Company Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Full Year 2023 Financial Outlook
Fourth Quarter 2022 Highlights: Net sales rose 4% (8% constant-currency) to a record $1,169.6 million. However, operating income fell 27% to $155.4 million, impacted by $35.6 million in impairment charges for prAna. Diluted EPS decreased 15% to $2.02, with impairment charges lowering it by $0.43. Full Year 2022: Net sales increased 11% (14% constant-currency) to $3,464.2 million, while operating income decreased 13% to $393.1 million. Diluted EPS declined 7% to $4.95. The company ended the year with $431 million in cash, no debt, and repurchased $286.9 million in stock.
- Record net sales of $3,464.2 million for 2022, an 11% increase.
- Full year cash and short-term investments stand at $431 million with no borrowings.
- Stock repurchase of $286.9 million during 2022.
- Operating income for Q4 2022 decreased 27% to $155.4 million.
- Diluted EPS fell 15% in Q4 2022, negatively impacted by $0.43 from impairment charges.
- Operating income for the full year decreased 13% to $393.1 million, a decline year-over-year.
Fourth Quarter 2022 Highlights
-
Net sales increased 4 percent (8 percent constant-currency) to a record
, compared to fourth quarter 2021.$1,169.6 million -
Operating income decreased 27 percent to
, or 13.3 percent of net sales, compared to fourth quarter 2021 operating income of$155.4 million , or 18.7 percent of net sales. Fourth quarter 2022 operating income includes$211.6 million of impairment charges related to prAna.$35.6 million -
Diluted earnings per share decreased 15 percent to
, compared to$2.02 in fourth quarter 2021. The prAna impairment charges negatively impacted diluted earnings per share by$2.39 .$0.43 -
Exited the quarter with
of cash and short-term investments and no borrowings.$431.0 million
Full Year 2022 Highlights
-
Net sales increased 11 percent (14 percent constant-currency) to a record
, compared to 2021.$3,464.2 million -
Operating income decreased 13 percent to
, or 11.3 percent of net sales, compared to 2021 operating income of$393.1 million , or 14.4 percent of net sales. 2022 operating income includes$450.5 million in prAna impairment charges.$35.6 million -
Diluted earnings per share decreased 7 percent to
, compared to 2021 diluted earnings per share of$4.95 .$5.33 -
The Company repurchased
of common stock during the year.$286.9 million
Full Year 2023 Financial Outlook
The following forward-looking statements reflect our expectations as of
-
Net sales of
to$3.57 representing net sales growth of 3 to 6 percent compared to 2022.$3.67 billion -
Operating income of
to$413 , representing operating margin of 11.6 to 12.2 percent.$448 million -
Diluted earnings per share of
to$5.15 .$5.55
Chairman, President and Chief Executive Officer
“We are entering 2023 in a position of strength, with strong consumer demand for our innovative products. With the early receipt of Spring merchandise, we are well positioned for timely deliveries, and have strategies in place to profitably and efficiently reduce inventory levels. Our financial strength, with over
“I’m confident we have the right strategies in place to unlock the significant growth opportunities we see across the business. We are investing in our strategic priorities to:
- accelerate profitable growth;
- create iconic products that are differentiated, functional and innovative;
- drive brand engagement through increased, focused demand creation investments;
- enhance consumer experiences by investing in capabilities to delight and retain consumers;
- amplify marketplace excellence, with digitally-led, omni-channel, global distribution; and
- empower talent that is driven by our core values, through a diverse and inclusive workforce.”
CFO's Commentary and Financial Review Presentation Available Online
For a detailed review of the Company's fourth quarter 2022 financial results, please refer to the CFO Commentary and Financial Review presentation furnished to the
Fourth Quarter 2022 Financial Results
(All comparisons are between fourth quarter 2022 and fourth quarter 2021, unless otherwise noted.)
Net sales increased 4 percent (8 percent constant-currency) to
Gross margin contracted 180 basis points to 50.4 percent of net sales from 52.2 percent of net sales for the comparable period in 2021. The primary driver of gross margin contraction was increased promotional activity, compared to exceptionally low promotions in the comparable period in 2021.
SG&A expenses increased 5 percent to
Impairment of goodwill and intangible assets related to prAna of
Operating income decreased 27 percent to
Income tax expense of
Net income decreased 20 percent to
Full Year 2022 Financial Results
(All comparisons are between full year 2022 and full year 2021, unless otherwise noted.)
Net sales increased 11 percent (14 percent constant-currency) to
Gross margin contracted 220 basis points to 49.4 percent of net sales from 51.6 percent of net sales in 2021.
SG&A expenses increased 11 percent to
Impairment of goodwill and intangible assets related to prAna of
Operating income decreased 13 percent to
Income tax expense of
Net income decreased 12 percent to
Balance Sheet as of
Cash, cash equivalents and short-term investments totaled
The Company had no borrowings as of
Inventories increased 59 percent to
Cash Flow for the Twelve Months Ended
Net cash used in operating activities was
Capital expenditures totaled
Share Repurchases for the Twelve Months Ended
The Company repurchased 3,235,327 shares of common stock for an aggregate of
At
Quarterly Cash Dividend
The Board of Directors approved a regular quarterly cash dividend of
Full Year 2023 Financial Outlook
(Additional financial outlook details can be found in the CFO Commentary and Financial Review presentation.)
The Company's first half and full year 2023 Financial Outlook is forward-looking in nature, and the following forward-looking statements reflect our expectations as of
Net sales are expected to increase 3 to 6 percent to
Gross margin is expected to expand approximately 60 basis points to approximately 50 percent of net sales from 49.4 percent of net sales in 2022.
SG&A expenses are expected to increase faster than net sales growth. SG&A expense, as a percent of net sales, is expected to be 38.3 to 39.0 percent, compared to SG&A expense as a percent of net sales of 37.7 percent in 2022.
Operating income is expected to be
Effective income tax rate is expected to be approximately 24.5 percent.
Net income is expected to be
Foreign Currency
- Foreign currency translation is anticipated to reduce 2023 net sales growth by approximately 30 basis points.
-
Foreign currency is expected to have an approximately
negative impact on diluted earnings per share due primarily to unfavorable foreign currency transactional effects from hedging of production.$0.05
Balance Sheet and Cash Flows
Operating cash flow is expected to be over
Capital expenditures are planned to be in the range of
First Half 2023 Financial Outlook
- Net sales growth of mid-single-digit percent, compared to first half 2022.
- Gross margin is anticipated to expand at a rate modestly below our full year 2023 gross margin outlook, with first quarter 2023 gross margin expected to be down compared to first quarter 2022.
- SG&A expenses are expected to grow faster than net sales growth, resulting in SG&A deleverage.
-
Diluted earnings per share is expected to be
to$0.75 . First half 2023 diluted earnings per share will be weighted to first quarter 2023, with essentially breakeven earnings in second quarter 2023. Please note second quarter is typically our lowest volume sales quarter and small changes in the timing of product shipments and expenses can have a material impact on reported results.$0.90
Conference Call
The Company will hold its fourth quarter 2022 conference call at
First Quarter 2023 Reporting Date
Supplemental Financial Information
Since
The non-GAAP financial measures should be viewed in addition to, and not in lieu of or superior to, our financial measures calculated in accordance with GAAP. The Company provides a reconciliation of non-GAAP measures to the most directly comparable financial measure calculated in accordance with GAAP. See the "Reconciliation of GAAP to Non-GAAP Financial Measures" table included herein. The non-GAAP financial measures presented may not be comparable to similarly titled measures reported by other companies.
Forward-Looking Statements
This document contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the Company’s expectations, anticipations or beliefs about the Company's ability to realize growth opportunities, financial position, inventory, full year 2023 net sales, gross margin, SG&A expenses, operating income, effective income tax rate, net income, diluted earnings per share, weighted average diluted shares outstanding, foreign currency translation, cash flows, and capital expenditures, and first half 2023 net sales, gross margin, SG&A expenses, and diluted earnings per share. Forward-looking statements often use words such as "will," "anticipate," "estimate," "expect," "should," "may" and other words and terms of similar meaning or reference future dates. The Company's expectations, beliefs and projections are expressed in good faith and are believed to have a reasonable basis; however, each forward-looking statement involves a number of risks and uncertainties, including those set forth in this document, those described in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors," and those that have been or may be described in other reports filed by the Company, including reports on Form 8-K. Potential risks and uncertainties include those relating to the impact of the COVID-19 pandemic on our operations; economic conditions, including inflationary pressures; supply chain disruptions, constraints and expenses; changes in consumer behavior and confidence; as well as geopolitical tensions. The Company does not undertake any duty to update any of the forward-looking statements after the date of this document to conform them to actual results or to reflect changes in events, circumstances or its expectations. New factors emerge from time to time and it is not possible for the Company to predict or assess the effects of all such factors or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement.
About
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) |
||||||||
|
||||||||
(in thousands) |
|
2022 |
|
2021 |
||||
ASSETS |
|
|
|
|
||||
Current Assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
430,241 |
|
$ |
763,404 |
||
Short-term investments |
|
|
722 |
|
|
|
131,145 |
|
Accounts receivable, net |
|
|
547,561 |
|
|
|
487,803 |
|
Inventories |
|
|
1,028,545 |
|
|
|
645,379 |
|
Prepaid expenses and other current assets |
|
|
129,872 |
|
|
|
86,306 |
|
Total current assets |
|
|
2,136,941 |
|
|
|
2,114,037 |
|
Property, plant and equipment, net |
|
|
291,214 |
|
|
|
291,088 |
|
Operating lease right-of-use assets |
|
|
324,409 |
|
|
|
330,928 |
|
Intangible assets, net |
|
|
81,558 |
|
|
|
101,908 |
|
|
|
|
51,694 |
|
|
|
68,594 |
|
Deferred income taxes |
|
|
94,162 |
|
|
|
92,121 |
|
Other non-current assets |
|
|
71,568 |
|
|
|
68,452 |
|
Total assets |
|
$ |
3,051,546 |
|
|
$ |
3,067,128 |
|
LIABILITIES AND EQUITY |
|
|
|
|
||||
Current Liabilities: |
|
|
|
|
||||
Accounts payable |
|
$ |
322,472 |
|
|
$ |
283,349 |
|
Accrued liabilities |
|
|
328,759 |
|
|
|
316,485 |
|
Operating lease liabilities |
|
|
68,685 |
|
|
|
67,429 |
|
Income taxes payable |
|
|
18,802 |
|
|
|
13,127 |
|
Total current liabilities |
|
|
738,718 |
|
|
|
680,390 |
|
Non-current operating lease liabilities |
|
|
310,625 |
|
|
|
317,666 |
|
Income taxes payable |
|
|
33,251 |
|
|
|
44,541 |
|
Deferred income taxes |
|
|
143 |
|
|
|
— |
|
Other long-term liabilities |
|
|
33,020 |
|
|
|
35,279 |
|
Total liabilities |
|
|
1,115,757 |
|
|
|
1,077,876 |
|
Total shareholders' equity |
|
|
1,935,789 |
|
|
|
1,989,252 |
|
Total liabilities and shareholders' equity |
|
$ |
3,051,546 |
|
|
$ |
3,067,128 |
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) |
||||||||||||||||
(In thousands, except per share amounts) |
|
Three Months Ended |
|
Twelve Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|||||||||
Net sales |
|
$ |
1,169,520 |
|
|
$ |
1,129,720 |
|
|
$ |
3,464,152 |
|
|
$ |
3,126,402 |
|
Cost of sales |
|
|
579,544 |
|
|
|
539,544 |
|
|
|
1,753,074 |
|
|
|
1,513,947 |
|
Gross profit |
|
|
589,976 |
|
|
|
590,176 |
|
|
|
1,711,078 |
|
|
|
1,612,455 |
|
Gross margin |
|
|
50.4 |
% |
|
|
52.2 |
% |
|
|
49.4 |
% |
|
|
51.6 |
% |
|
|
|
|
|
|
|
|
|
||||||||
Selling, general and administrative expenses |
|
|
405,093 |
|
|
|
384,047 |
|
|
|
1,304,394 |
|
|
|
1,180,323 |
|
Impairment of goodwill and intangibles assets |
|
|
35,600 |
|
|
|
— |
|
|
|
35,600 |
|
|
|
— |
|
Net licensing income |
|
|
6,121 |
|
|
|
5,439 |
|
|
|
22,020 |
|
|
|
18,372 |
|
Operating income |
|
|
155,404 |
|
|
|
211,568 |
|
|
|
393,104 |
|
|
|
450,504 |
|
Interest income, net |
|
|
1,054 |
|
|
|
308 |
|
|
|
2,713 |
|
|
|
1,380 |
|
Other non-operating income (expense), net |
|
|
3,253 |
|
|
|
24 |
|
|
|
1,593 |
|
|
|
(373 |
) |
Income before income tax |
|
|
159,711 |
|
|
|
211,900 |
|
|
|
397,410 |
|
|
|
451,511 |
|
Income tax expense |
|
|
(34,021 |
) |
|
|
(54,939 |
) |
|
|
(85,970 |
) |
|
|
(97,403 |
) |
Net income |
|
$ |
125,690 |
|
|
$ |
156,961 |
|
|
$ |
311,440 |
|
|
$ |
354,108 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
$ |
2.02 |
|
|
$ |
2.41 |
|
|
$ |
4.96 |
|
|
$ |
5.37 |
|
Diluted |
|
$ |
2.02 |
|
|
$ |
2.39 |
|
|
$ |
4.95 |
|
|
$ |
5.33 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
|
62,123 |
|
|
|
65,229 |
|
|
|
62,754 |
|
|
|
65,942 |
|
Diluted |
|
|
62,311 |
|
|
|
65,617 |
|
|
|
62,970 |
|
|
|
66,415 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) |
|||||||
|
Year Ended |
||||||
(in thousands) |
2022 |
|
2021 |
||||
Cash flows from operating activities: |
|
|
|
||||
Net income |
$ |
311,440 |
|
|
$ |
354,108 |
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
|
||||
Depreciation, amortization, and non-cash lease expense |
|
117,399 |
|
|
|
115,571 |
|
Provision for uncollectible accounts receivable |
|
(2,044 |
) |
|
|
(10,758 |
) |
Loss on disposal or impairment of investments, property, plant and equipment, right-of-use assets, and intangible assets |
|
38,194 |
|
|
|
1,233 |
|
Deferred income taxes |
|
(8,118 |
) |
|
|
(9,798 |
) |
Stock-based compensation |
|
21,021 |
|
|
|
19,126 |
|
Changes in operating assets and liabilities: |
|
|
|
||||
Accounts receivable |
|
(64,495 |
) |
|
|
(31,622 |
) |
Inventories |
|
(399,851 |
) |
|
|
(100,261 |
) |
Prepaid expenses and other current assets |
|
(25,749 |
) |
|
|
(24,858 |
) |
Other assets |
|
(2,475 |
) |
|
|
1,231 |
|
Accounts payable |
|
40,429 |
|
|
|
75,513 |
|
Accrued liabilities |
|
20,683 |
|
|
|
66,457 |
|
Income taxes payable |
|
(5,871 |
) |
|
|
(15,248 |
) |
Operating lease assets and liabilities |
|
(62,749 |
) |
|
|
(85,176 |
) |
Other liabilities |
|
(3,055 |
) |
|
|
(1,112 |
) |
Net cash provided by (used in) operating activities |
|
(25,241 |
) |
|
|
354,406 |
|
Cash flows from investing activities: |
|
|
|
||||
Purchases of short-term investments |
|
(44,876 |
) |
|
|
(130,191 |
) |
Sales and maturities of short-term investments |
|
176,083 |
|
|
|
1,184 |
|
Capital expenditures |
|
(58,467 |
) |
|
|
(34,744 |
) |
Net cash provided by (used in) investing activities |
|
72,740 |
|
|
|
(163,751 |
) |
Cash flows from financing activities: |
|
|
|
||||
Proceeds from credit facilities |
|
52,918 |
|
|
|
38,334 |
|
Repayments on credit facilities |
|
(52,979 |
) |
|
|
(38,156 |
) |
Payment of line of credit issuance fees |
|
(604 |
) |
|
|
— |
|
Proceeds from issuance of common stock related to stock-based compensation |
|
6,588 |
|
|
|
28,783 |
|
Tax payments related to stock-based compensation |
|
(4,229 |
) |
|
|
(5,812 |
) |
Repurchase of common stock |
|
(287,443 |
) |
|
|
(165,415 |
) |
Cash dividends paid |
|
(75,082 |
) |
|
|
(68,623 |
) |
Net cash used in financing activities |
|
(360,831 |
) |
|
|
(210,889 |
) |
Net effect of exchange rate changes on cash |
|
(19,831 |
) |
|
|
(7,087 |
) |
Net decrease in cash and cash equivalents |
|
(333,163 |
) |
|
|
(27,321 |
) |
Cash and cash equivalents, beginning of period |
|
763,404 |
|
|
|
790,725 |
|
Cash and cash equivalents, end of period |
$ |
430,241 |
|
|
$ |
763,404 |
|
Supplemental disclosures of cash flow information: |
|
|
|
||||
Cash paid during the year for income taxes |
$ |
92,110 |
|
|
$ |
129,483 |
|
Supplemental disclosures of non-cash investing and financing activities: |
|
|
|
||||
Property, plant and equipment acquired through increase in liabilities |
$ |
11,103 |
|
|
$ |
5,853 |
|
Reconciliation of GAAP to Non-GAAP Financial Measures Net Sales Growth - Constant-currency Basis (Unaudited) |
||||||||||||||||||||
|
|
Three Months Ended |
||||||||||||||||||
(In millions, except percentage changes) |
|
Reported Net Sales 2022 |
|
Adjust for Foreign Currency Translation |
|
Constant- currency Net Sales 2022(1) |
|
Reported Net Sales 2021 |
|
Reported Net Sales % Change |
|
Constant- currency Net Sales % Change(1) |
||||||||
Geographical |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
$ |
780.8 |
|
$ |
— |
|
|
$ |
780.8 |
|
|
$ |
762.1 |
|
|
|
|
|
|
|
|
|
164.0 |
|
|
|
27.2 |
|
|
191.2 |
|
|
172.8 |
|
(5)% |
|
|
|||
|
|
|
132.8 |
|
|
|
17.3 |
|
|
|
150.1 |
|
|
|
113.6 |
|
|
|
|
|
|
|
|
92.0 |
|
|
|
7.5 |
|
|
|
99.5 |
|
|
|
81.2 |
|
|
|
|
|
Total |
|
$ |
1,169.6 |
|
|
$ |
52.0 |
|
|
$ |
1,221.6 |
|
|
$ |
1,129.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Brand |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Columbia |
|
$ |
961.3 |
|
|
$ |
45.3 |
|
|
$ |
1,006.6 |
|
|
$ |
894.2 |
|
|
|
|
|
SOREL |
|
|
142.6 |
|
|
|
5.8 |
|
|
|
148.4 |
|
|
|
163.4 |
|
|
(13)% |
|
(9)% |
prAna |
|
|
32.3 |
|
|
|
— |
|
|
|
32.3 |
|
|
|
34.3 |
|
|
(6)% |
|
(6)% |
|
|
|
33.4 |
|
|
|
0.9 |
|
|
|
34.3 |
|
|
|
37.8 |
|
|
(12)% |
|
(9)% |
Total |
|
$ |
1,169.6 |
|
|
$ |
52.0 |
|
|
$ |
1,221.6 |
|
|
$ |
1,129.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Product Category |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Apparel, Accessories and Equipment |
|
$ |
900.5 |
|
|
$ |
37.4 |
|
|
$ |
937.9 |
|
|
$ |
846.1 |
|
|
|
|
|
Footwear |
|
|
269.1 |
|
|
|
14.6 |
|
|
|
283.7 |
|
|
|
283.6 |
|
|
(5)% |
|
—% |
Total |
|
$ |
1,169.6 |
|
|
$ |
52.0 |
|
|
$ |
1,221.6 |
|
|
$ |
1,129.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Channel |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Wholesale |
|
$ |
514.5 |
|
|
$ |
26.0 |
|
|
$ |
540.5 |
|
|
$ |
504.5 |
|
|
|
|
|
DTC |
|
|
655.1 |
|
|
|
26.0 |
|
|
|
681.1 |
|
|
|
625.2 |
|
|
|
|
|
Total |
|
$ |
1,169.6 |
|
|
$ |
52.0 |
|
|
$ |
1,221.6 |
|
|
$ |
1,129.7 |
|
|
|
|
|
(1) Constant-currency net sales is a non-GAAP financial measure. See “Supplemental Financial Information” above for further information. |
Reconciliation of GAAP to Non-GAAP Financial Measures Net Sales Growth - Constant-currency Basis (Unaudited) |
||||||||||||||||||||
|
|
Twelve Months Ended |
||||||||||||||||||
(In millions, except percentage changes) |
|
Reported Net Sales 2022 |
|
Adjust for Foreign Currency Translation |
|
Constant- currency Net Sales 2022(1) |
|
Reported Net Sales 2021 |
|
Reported Net Sales % Change |
|
Constant- currency Net Sales % Change(1) |
||||||||
Geographical |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
$ |
2,302.2 |
|
$ |
— |
|
|
$ |
2,302.2 |
|
|
$ |
2,060.3 |
|
|
|
|
|
|
|
|
|
473.9 |
|
|
|
51.8 |
|
|
525.7 |
|
|
465.5 |
|
|
|
|
|||
|
|
|
438.6 |
|
|
|
41.9 |
|
|
|
480.5 |
|
|
|
382.1 |
|
|
|
|
|
|
|
|
249.5 |
|
|
|
11.3 |
|
|
|
260.8 |
|
|
|
218.5 |
|
|
|
|
|
Total |
|
$ |
3,464.2 |
|
|
$ |
105.0 |
|
|
$ |
3,569.2 |
|
|
$ |
3,126.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Brand |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Columbia |
|
$ |
2,864.3 |
|
|
$ |
94.2 |
|
|
$ |
2,958.5 |
|
|
$ |
2,557.4 |
|
|
|
|
|
SOREL |
|
|
347.3 |
|
|
|
9.1 |
|
|
|
356.4 |
|
|
|
320.9 |
|
|
|
|
|
prAna |
|
|
143.1 |
|
|
|
— |
|
|
|
143.1 |
|
|
|
141.9 |
|
|
|
|
|
|
|
|
109.5 |
|
|
|
1.7 |
|
|
|
111.2 |
|
|
|
106.2 |
|
|
|
|
|
Total |
|
$ |
3,464.2 |
|
|
$ |
105.0 |
|
|
$ |
3,569.2 |
|
|
$ |
3,126.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Product Category |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Apparel, Accessories and Equipment |
|
$ |
2,661.1 |
|
|
$ |
74.6 |
|
|
$ |
2,735.7 |
|
|
$ |
2,389.2 |
|
|
|
|
|
Footwear |
|
|
803.1 |
|
|
|
30.4 |
|
|
|
833.5 |
|
|
|
737.2 |
|
|
|
|
|
Total |
|
$ |
3,464.2 |
|
|
$ |
105.0 |
|
|
$ |
3,569.2 |
|
|
$ |
3,126.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Channel |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Wholesale |
|
$ |
1,867.7 |
|
|
$ |
57.8 |
|
|
$ |
1,925.5 |
|
|
$ |
1,660.4 |
|
|
|
|
|
DTC |
|
|
1,596.5 |
|
|
|
47.2 |
|
|
|
1,643.7 |
|
|
|
1,466.0 |
|
|
|
|
|
Total |
|
$ |
3,464.2 |
|
|
$ |
105.0 |
|
|
$ |
3,569.2 |
|
|
$ |
3,126.4 |
|
|
|
|
|
(1) Constant-currency net sales is a non-GAAP financial measure. See “Supplemental Financial Information” above for further information. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230202005725/en/
Vice President of Investor Relations and Strategic Planning
(503) 985-4112
aburns@columbia.com
Source:
FAQ
What were the fourth quarter 2022 net sales for COLM?
How did COLM's diluted earnings per share change in Q4 2022?
What was the full year 2022 operating income for COLM?